Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Lipton RB, Hutchinson S, Ailani J, Reed ML, Fanning KM, Manack Adams A, Buse DC.

Headache. 2019 Sep 22. doi: 10.1111/head.13642. [Epub ahead of print]

PMID:
31544244
2.

Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.

Lipton RB, Munjal S, Buse DC, Alam A, Fanning KM, Reed ML, Schwedt TJ, Dodick DW.

Headache. 2019 Sep;59(8):1310-1323. doi: 10.1111/head.13588. Epub 2019 Aug 13.

3.

Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Buse DC, Fanning KM, Reed ML, Murray S, Dumas PK, Adams AM, Lipton RB.

Headache. 2019 Sep;59(8):1286-1299. doi: 10.1111/head.13613. Epub 2019 Aug 12.

4.

Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.

Pavlovic JM, Yu JS, Silberstein SD, Reed ML, Kawahara SH, Cowan RP, Dabbous F, Campbell KL, Shewale AR, Pulicharam R, Kowalski JW, Viswanathan HN, Lipton RB.

Cephalalgia. 2019 Apr;39(4):465-476. doi: 10.1177/0333102418825373. Epub 2019 Mar 9.

5.

Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.

Dodick DW, Reed ML, Fanning KM, Munjal S, Alam A, Buse DC, Schwedt TJ, Lipton RB.

Cephalalgia. 2019 Jun;39(7):873-882. doi: 10.1177/0333102418825346. Epub 2019 Feb 7.

PMID:
30732460
6.
7.

Sleep Disorders Among People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Buse DC, Rains JC, Pavlovic JM, Fanning KM, Reed ML, Manack Adams A, Lipton RB.

Headache. 2019 Jan;59(1):32-45. doi: 10.1111/head.13435. Epub 2018 Nov 1.

8.

Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.

Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, Schwedt TJ, Dodick DW.

Headache. 2018 Oct;58(9):1408-1426. doi: 10.1111/head.13407. Epub 2018 Oct 20.

PMID:
30341895
9.

Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Lipton RB, Fanning KM, Buse DC, Martin VT, Reed ML, Manack Adams A, Goadsby PJ.

Headache. 2018 Jul;58(7):933-947. doi: 10.1111/head.13342. Epub 2018 Jul 19.

PMID:
30024028
10.

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.

Schwedt TJ, Alam A, Reed ML, Fanning KM, Munjal S, Buse DC, Dodick DW, Lipton RB.

J Headache Pain. 2018 May 24;19(1):38. doi: 10.1186/s10194-018-0865-z.

11.

The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility.

Steiner TJ, Buse DC, Al Jumah M, Westergaard ML, Jensen RH, Reed ML, Prilipko L, Mennini FS, Láinez MJA, Ravishankar K, Sakai F, Yu SY, Fontebasso M, Al Khathami A, MacGregor EA, Antonaci F, Tassorelli C, Lipton RB; Lifting The Burden: The Global Campaign against Headache.

J Headache Pain. 2018 Feb 14;19(1):15. doi: 10.1186/s10194-018-0842-6.

12.

Regulation of Eag by Ca2+/calmodulin controls presynaptic excitability in Drosophila.

Bronk P, Kuklin EA, Gorur-Shandilya S, Liu C, Wiggin TD, Reed ML, Marder E, Griffith LC.

J Neurophysiol. 2018 May 1;119(5):1665-1680. doi: 10.1152/jn.00820.2017. Epub 2018 Jan 24.

13.

Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study.

Buse DC, Powers SW, Gelfand AA, VanderPluym JH, Fanning KM, Reed ML, Adams AM, Lipton RB.

Headache. 2018 Apr;58(4):512-524. doi: 10.1111/head.13254. Epub 2018 Jan 22.

PMID:
29355924
14.

Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.

Lipton RB, Reed ML, Kurth T, Fanning KM, Buse DC.

Headache. 2017 Nov;57(10):1507-1521. doi: 10.1111/head.13179. Epub 2017 Oct 9.

PMID:
28990165
15.

Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.

Serrano D, Lipton RB, Scher AI, Reed ML, Stewart WBF, Adams AM, Buse DC.

J Headache Pain. 2017 Oct 4;18(1):101. doi: 10.1186/s10194-017-0787-1.

16.

Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.

Lipton RB, Munjal S, Buse DC, Bennett A, Fanning KM, Burstein R, Reed ML.

Headache. 2017 Jul;57(7):1026-1040. doi: 10.1111/head.13115. Epub 2017 Jun 11.

PMID:
28603893
17.

Platelet-Rich Plasma for the Treatment of Female Pattern Hair Loss: A Patient Survey.

Laird ME, Lo Sicco KI, Reed ML, Brinster NK.

Dermatol Surg. 2018 Jan;44(1):130-132. doi: 10.1097/DSS.0000000000001109. No abstract available.

PMID:
28375977
18.

Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale.

Lipton RB, Buse DC, Adams AM, Varon SF, Fanning KM, Reed ML.

Headache. 2017 Apr;57(4):570-585. doi: 10.1111/head.13028. Epub 2017 Feb 10.

19.

Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.

Buse DC, Reed ML, Fanning KM, Kurth T, Lipton RB.

Headache. 2017 Jan;57(1):31-44. doi: 10.1111/head.12962. Epub 2016 Nov 12.

PMID:
27861837
20.

Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.

Lipton RB, Munjal S, Buse DC, Fanning KM, Bennett A, Reed ML.

Headache. 2016 Nov;56(10):1635-1648. doi: 10.1111/head.12941. Epub 2016 Oct 12.

PMID:
27731896
21.

Spinal devices in the United States-investigational device exemption trials and premarket approval of class III devices.

Golish SR, Reed ML.

Spine J. 2017 Jan;17(1):150-157. doi: 10.1016/j.spinee.2016.09.015. Epub 2016 Oct 11. Review.

PMID:
27737804
22.

A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.

Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML.

Headache. 2016 Sep;56(8):1280-9. doi: 10.1111/head.12878. Epub 2016 Jun 28.

23.

Failure Modes during Low-Voltage Electrowetting.

Mibus M, Hu X, Knospe C, Reed ML, Zangari G.

ACS Appl Mater Interfaces. 2016 Jun 22;8(24):15767-77. doi: 10.1021/acsami.6b02791. Epub 2016 Jun 10.

PMID:
27253515
24.

Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, Lipton RB.

Headache. 2016 May;56(5):821-834. doi: 10.1111/head.12774. Epub 2016 May 3.

25.

Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study.

Buse DC, Scher AI, Dodick DW, Reed ML, Fanning KM, Manack Adams A, Lipton RB.

Mayo Clin Proc. 2016 Apr 25. pii: S0025-6196(16)00126-9. doi: 10.1016/j.mayocp.2016.02.013. [Epub ahead of print]

26.

Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention Study.

Martin VT, Pavlovic J, Fanning KM, Buse DC, Reed ML, Lipton RB.

Headache. 2016 Feb;56(2):292-305. doi: 10.1111/head.12763. Epub 2016 Jan 21.

PMID:
26797693
27.

Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study.

Martin VT, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB.

Headache. 2016 Jan;56(1):118-31. doi: 10.1111/head.12731. Epub 2015 Nov 19.

PMID:
26581563
29.

Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM).

Lipton RB, Serrano D, Buse DC, Pavlovic JM, Blumenfeld AM, Dodick DW, Aurora SK, Becker WJ, Diener HC, Wang SJ, Vincent MB, Hindiyeh NA, Starling AJ, Gillard PJ, Varon SF, Reed ML.

Cephalalgia. 2016 Mar;36(3):203-15. doi: 10.1177/0333102415583982. Epub 2015 May 22.

30.

Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.

Buse DC, Serrano D, Reed ML, Kori SH, Cunanan CM, Adams AM, Lipton RB.

Headache. 2015 Jun;55(6):825-39. doi: 10.1111/head.12556. Epub 2015 Apr 17.

PMID:
25881857
31.

Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.

Serrano D, Buse DC, Manack Adams A, Reed ML, Lipton RB.

Headache. 2015 Apr;55(4):502-18. doi: 10.1111/head.12553.

PMID:
25881676
32.

Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine.

Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC.

Neurology. 2015 Feb 17;84(7):688-95. doi: 10.1212/WNL.0000000000001256. Epub 2015 Jan 21.

33.

Attention-deficit/hyperactivity disorder symptoms in adults with self-reported epilepsy: Results from a national epidemiologic survey of epilepsy.

Ettinger AB, Ottman R, Lipton RB, Cramer JA, Fanning KM, Reed ML.

Epilepsia. 2015 Feb;56(2):218-24. doi: 10.1111/epi.12897. Epub 2015 Jan 15.

34.

Recalled maltreatment, migraine, and tension-type headache: results of the AMPP study.

Tietjen GE, Buse DC, Fanning KM, Serrano D, Reed ML, Lipton RB.

Neurology. 2015 Jan 13;84(2):132-40. doi: 10.1212/WNL.0000000000001120. Epub 2014 Dec 24.

35.

Large-volume vitrification of human biopsied and non-biopsied blastocysts: a simple, robust technique for cryopreservation.

Reed ML, Said AH, Thompson DJ, Caperton CL.

J Assist Reprod Genet. 2015 Feb;32(2):207-14. doi: 10.1007/s10815-014-0395-9. Epub 2014 Dec 3.

36.

The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results.

Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, Lipton RB.

Cephalalgia. 2015 Jun;35(7):563-78. doi: 10.1177/0333102414552532. Epub 2014 Oct 10.

37.

Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results.

Reed ML, Fanning KM, Serrano D, Buse DC, Lipton RB.

Headache. 2015 Jan;55(1):76-87. doi: 10.1111/head.12450. Epub 2014 Sep 24.

PMID:
25250833
38.

Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.

Lipton RB, Serrano D, Pavlovic JM, Manack AN, Reed ML, Turkel CC, Buse DC.

Headache. 2014 May;54(5):830-49. doi: 10.1111/head.12332. Epub 2014 Apr 17.

PMID:
24527745
39.

Chronic rhinitis and its association with headache frequency and disability in persons with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.

Martin VT, Fanning KM, Serrano D, Buse DC, Reed ML, Bernstein JA, Lipton RB.

Cephalalgia. 2014 Apr;34(5):336-48. doi: 10.1177/0333102413512031. Epub 2013 Nov 25.

PMID:
24275145
40.

Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.

Lipton RB, Serrano D, Nicholson RA, Buse DC, Runken MC, Reed ML.

Headache. 2013 Nov-Dec;53(10):1548-63. doi: 10.1111/head.12201. Epub 2013 Aug 28.

PMID:
23992516
41.

Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.

Lipton RB, Buse DC, Serrano D, Holland S, Reed ML.

Headache. 2013 Sep;53(8):1300-11. doi: 10.1111/head.12154. Epub 2013 Jul 23.

PMID:
23879870
42.

Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets.

Zaraket H, Bridges OA, Duan S, Baranovich T, Yoon SW, Reed ML, Salomon R, Webby RJ, Webster RG, Russell CJ.

J Virol. 2013 Sep;87(17):9911-22. doi: 10.1128/JVI.01175-13. Epub 2013 Jul 3.

43.

Effects of switching acute treatment on disability in migraine patients using triptans.

Serrano D, Buse DC, Kori SH, Papapetropoulos S, Cunanan CM, Manack AN, Reed ML, Lipton RB.

Headache. 2013 Oct;53(9):1415-29. doi: 10.1111/head.12164. Epub 2013 Jun 28.

PMID:
23808937
44.

Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.

Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB.

Headache. 2013 Sep;53(8):1278-99. doi: 10.1111/head.12150. Epub 2013 Jun 28.

PMID:
23808666
45.

Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement.

Reed ML, Merriam GR, Kargi AY.

Front Endocrinol (Lausanne). 2013 Jun 4;4:64. doi: 10.3389/fendo.2013.00064. eCollection 2013.

46.

Three-phase contact force equilibrium of liquid drops at hydrophilic and superhydrophobic surfaces.

Zhu J, Zangari G, Reed ML.

J Colloid Interface Sci. 2013 Aug 15;404:179-82. doi: 10.1016/j.jcis.2013.04.037. Epub 2013 May 6.

PMID:
23726384
47.

Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.

Galloway SE, Reed ML, Russell CJ, Steinhauer DA.

PLoS Pathog. 2013 Feb;9(2):e1003151. doi: 10.1371/journal.ppat.1003151. Epub 2013 Feb 14.

48.

Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.

Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB.

J Neurol Sci. 2013 Mar 15;326(1-2):10-7. doi: 10.1016/j.jns.2012.12.020. Epub 2013 Feb 8.

PMID:
23394974
49.

Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

Lipton RB, Buse DC, Saiers J, Serrano D, Reed ML.

J Med Econ. 2013;16(4):490-9. doi: 10.3111/13696998.2013.770748. Epub 2013 Feb 11.

PMID:
23356422
50.

Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB.

Value Health. 2013 Jan-Feb;16(1):31-8. doi: 10.1016/j.jval.2012.08.2212.

Supplemental Content

Support Center